Citation Impact
Citing Papers
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
2008
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Identification of the haematopoietic stem cell niche and control of the niche size
2003 StandoutNature
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
1991 Standout
Chondroclasts and endothelial cells collaborate in the process of cartilage resorption
1992
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Endothelin-1 Is a Potent Regulator of Human Bone Cell Metabolism In Vitro
1997
Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties
1993
Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism
1989
Systemic manifestations and comorbidities of COPD
2009
Nucleotide signalling during inflammation
2014 StandoutNature
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation
2006 StandoutNobel
Effects of sclerostin antibody on healing of a non‐critical size femoral bone defect
2012
Physiology of Bone
2009
Pathogenesis of osteoporosis
2003
Therapeutic uses of vitamin D analogues
2001
Osteoblastic cells regulate the haematopoietic stem cell niche
2003 StandoutNature
Bone “mass” and the “mechanostat”: A proposal
1987
Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.
1994
Vitamin D Deficiency
2007 Standout
MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes
1998 Standout
Tartrate-resistant acid ATPase as a cytochemical marker for osteoclasts.
1989
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein
1993 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
P2X7 receptors in the nervous system
2006
Prediction of bone density from vitamin D receptor alleles
1994 StandoutNature
Skeletal remodeling in health and disease
2007 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Pathophysiology and Therapeutic Potential of Purinergic Signaling
2006
Ion channels and transporters in osteoclasts
2008
Cell cycle arrest by prostaglandin A1 at the G1/S phase interface with up‐regulation of oncogenes in S‐49 cyc− cells
1994
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Cellular Distribution and Functions of P2 Receptor Subtypes in Different Systems
2004
Cellular and Molecular Mechanisms in the Regulation and Function of Osteoclasts
1991
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
2006 Standout
Parathyroid hormone: a double-edged sword for bone metabolism
2004
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
2010 StandoutNature
Molecular properties of P2X receptors
2006
P2X receptors as cell-surface ATP sensors in health and disease
2006 Nature
Cell biology of the osteoclast
1999
Is pannexin the pore associated with the P2X7 receptor?
2013
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
2013
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Osteoclast differentiation and activation
2003 StandoutNature
NFAT and Osterix cooperatively regulate bone formation
2005
Calcitriol Treatment Is Not Effective in Postmenopausal Osteoporosis
1989
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
1992 Standout
Resolution of Bisphosphonate-Associated Osteonecrosis of the Mandible: Possible Application for Intermittent Low-Dose Parathyroid Hormone [rhPTH(1-34)]
2007
Pharmacology of P2X channels
2006
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation
2005
Management of patients on chronic glucocorticoid therapy: an endocrine perspective
2003
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study
2001
Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease
2011
Characterization of a functional P2X7‐like receptor in cerebellar granule neurons from P2X7 knockout mice
2005
Osteoporosis after solid organ and bone marrow transplantation
2003
Anabolic Actions of Parathyroid Hormone on Bone*
1993
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Mechanisms of Bone Metastasis
2004 Standout
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study
2001
Biochemical signal transduction of mechanical strain in osteoblast-like cells
1991
Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis
1990 Standout
Bisphosphonates
1991
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
2002 Standout
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Frailty in elderly people
2013 Standout
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
2009
High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry
1999
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
2003
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Involutional Osteoporosis
1986 Standout
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
2011
The architecture of bone marrow cell populations
1990
Wnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation
2007
Bone Resorption by Osteoclasts
2000 StandoutScience
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
2008 StandoutNature
Fracture after cardiac transplantation: a prospective longitudinal study.
1996
Anabolic and Catabolic Regimens of Human Parathyroid Hormone 1–34 Elicit Bone- and Envelope-Specific Attenuation of Skeletal Effects in Sost-Deficient Mice
2011
Sclerostin: A gem from the genome leads to bone-building antibodies
2010
Generation and reproductive phenotypes of mice lacking estrogen receptor β
1998 StandoutNobel
Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
2002
Isolation and characterization of osteoblast precursor cells from human bone marrow
1996
Biology of Osteoclast Activation in Cancer
2001
Tetracycline-based histological analysis of bone remodeling
1969
Signaling at Purinergic P2X Receptors
2008
Extracellular Nucleotides Act Through P2X7 Receptors to Activate NF-κB in Osteoclasts
2004
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
1998 Standout
Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey
2011
Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1
1999
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures
1992
Calcium nutrition and bone health in the elderly
1982
Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis.
1984
Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers
2001
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis
1985
A Key Role for Redox Signaling in Rapid P2X7 Receptor-Induced IL-1β Processing in Human Monocytes
2008
Risk Factors for Hip Fracture in White Women
1995 Standout
Males Have Larger Skeletal Size and Bone Mass Than Females, Despite Comparable Body Size
2005
Identification of Estrogen Receptor β2, A Functional Variant of Estrogen Receptor β Expressed in Normal Rat Tissues
1998
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
The hematogenous origin of osteoclasts: Experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors
1981
Automated three-dimensional characterization of osteoclastic resorption lacunae by stereoscopic scanning electron microscopy
1994
Osteoblasts and The Hematopoietic Microenvironment
1999
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog Vertebra
2003
Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R−/− Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes
2006
Vitamin D supplementation in elderly nursing home residents increases 25(OH)D but not 1,25(OH)2D
1990
Calcineurin regulates bone formation by the osteoblast
2005
Human Aging: Usual and Successful
1987 StandoutScience
Intracapsular Hip Fracture and the Region-Specific Loss of Cortical Bone: Analysis by Peripheral Quantitative Computed Tomography
2001
Changes in Bone Density With Lactation
1993
Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo
2006
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Chemical Implications for Antitumor and Antiviral Prostaglandins: Reaction of Δ7-Prostaglandin A1 and Prostaglandin A1 Methyl Esters with Thiols
1997 StandoutNobel
Works of W.S.S. Jee being referenced
Adaptation of cancellous bone to aging and immobilization in the rat: A single photon absorptiometry and histomorphometry study
1990
Partial loss of anabolic effect of prostaglandin E2 on bone after its withdrawal in rats
1991
Effect of the Interaction of Parathyroid Hormone and Cyclosporine A on Bone Mineral Metabolism in the Rat
2001
Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2
1992
Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized rats
1990
Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment
1997
Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model
2010
THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVO
1994
Predictors of Bone Mass by Peripheral Quantitative Computed Tomography in Early Adolescent Girls
2001
Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in rats
1995
Deletion of the P2X7Nucleotide Receptor Reveals Its Regulatory Roles in Bone Formation and Resorption
2003
Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model
1997
Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats
1995
MYCOPHENOLATE MOFETIL: A PROMISING NEW IMMUNOSUPPRESSANT THAT DOES NOT CAUSE BONE LOSS IN THE RAT1,2
1998
Treatment with a sclerostin antibody increases cancellous bone formation and bone mass regardless of marrow composition in adult female rats
2010
Chiral pharmacokinetics of rac‐flurbiprofen and pharmacodynamics of anabolic bone response in the normal rat
1994
New Bone Formation with Teriparatide [Human Parathyroid Hormone-(1–34)] Is Not Retarded by Long-Term Pretreatment with Alendronate, Estrogen, or Raloxifene in Ovariectomized Rats
2003
On the rat model of human osteopenias and osteoporoses
1992
Bio-assay of responses of growing bones to cortisol.
1967
T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.
1996
Ethane-1-hydroxy-1, 1-diphosphonate (EHDP) effects on growth and modeling of the rat tibia
1975
Perspectives on osteoporosis research: Its focus and some insights from a new paradigm
1995
Bone cell kinetics during longitudinal bone growth in the rat
1980
Corticosteroid and bone
1970
Effects of CP-336,156, a New, Nonsteroidal Estrogen Agonist/Antagonist, on Bone, Serum Cholesterol, Uterus, and Body Composition in Rat Models
1998
Rapamycin: A bone sparing immunosuppressant?
1995
The comparative effects of dichloromethylene diphosphonate (Cl2MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia
1977
The effects of prostaglandin E2 in growing rats: Increased metaphyseal hard tissue and cortico-endosteal bone formation
1985
Immunosuppressant Use Without Bone Loss—Implications for Bone Loss After Transplantation
2001
Effect of Dichloromethane Diphosphonate on Cortisol-Induced Bone Loss in Young Adult Rabbits
1981
Effects of prostaglandin E2 and F2α on the skeleton of osteopenic ovariectomized rats
1995
Bone lining cells: structure and function.
1989
Distribution and Toxicity of 239Pu in Bone
1972
The bone lining cell: A distinct phenotype?
1987
Humoral and ionic regulation of osteoclast acidity
1986
The effects of prostaglandin E2 in rapidly growing rats: Depressed longitudinal and radial growth and increased metaphyseal hard tissue mass
1985
Characterization of endosteal bone‐lining cells from fatty marrow bone sites in adult beagles
1980
The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2
1987
Effects of spaceflight on trabecular bone in rats
1983
Bone mineral metabolism in T lymphocyte–deficient and –replete strains of rat
1995
Principles in bone physiology.
2000
The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat
1979
Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A—Induced osteopenia in oophorectomized rats
1996
Immobilization-associated osteoporosis in primates
1986
The Role of Testosterone in Cyclosporine-Induced Osteopenia
1997
Role of vitamin D in maternal skeletal changes during pregnancy and lactation: A histomorphometric study
1982
Human parathyroid hormone-(1–38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats
1995
Long-Term Dosing of Arzoxifene Lowers Cholesterol, Reduces Bone Turnover, and Preserves Bone Quality in Ovariectomized Rats
2002
Variations in mineral apposition rate of trabecular bone within the beagle skeleton
1981
Overview: animal models of osteopenia and osteoporosis.
2001
1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.
1982
Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
2007